๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Spectrum of chronic hepatic allograft rejection and arteriopathy and the controversy of centrilobular necrosis

โœ Scribed by Anthony J. Demetris


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
232 KB
Volume
6
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Acute hepatic allograft rejection: A com
โœ Michael O. Lovell; K. Vincent Speeg; Glenn A. Halff; D. Kimberley Molina; Franci ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB

The histologic diagnosis of acute hepatic allograft rejection is usually based upon the identification of characteristic portal tract features. In addition to these, centrilobular alterations such as central vein endothelialitis, zone 3 inflammation, and hepatocyte necrosis may also be seen during e

Evolving concepts in the diagnosis, path
โœ Wiesner, Russell H. ;Batts, Kenneth P. ;Krom, Ruud A. F. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 622 KB

Chronic hepatic allograft rejection is characterized by the histological findings of ductopenia and a decreased number of hepatic arteries in portal tracts in the presence of foam cell (obliterative) arteriopathy. Recent studies have extended the histological spectrum of chronic rejection to include

The effect of a positive T-lymphocytotox
โœ Bathgate, Andrew J. ;McColl, Mary ;Garden, O. James ;Forsythe, John L. ;Madhavan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 82 KB

The influence of crossmatching in liver transplantation is still controversial, and at present, our unit does not alter management according to the result of standard lymphocytotoxicity testing. This study retrospectively assessed outcome of grafts transplanted in the presence of preformed antidonor

Update of the International Banff Schema
โœ An International Panel ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 357 KB

In contrast with other vascularized allografts, chronic liver allograft rejection is uncommon. Over the last two decades, the incidence at 5 years after transplantation has decreased from 15% to 20% in the 1980s to an expected incidence of 3% to 5% in current liver allograft recipients. 1 This is li